JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2015, Vol. 29 ›› Issue (3): 65-71.doi: 10.6040/j.issn.1673-3770.0.2014.293
Previous Articles Next Articles
CHEN Chunli1, SONG Zongming2, JIA Xinguo3, ZHOU Zhonglou2, WANG Zhaoyang3
CLC Number:
| [1] Bird A C. The Bowman lecture. Towards an understanding of age-related macular disease[J]. Eye, 2003, 17(4):457-466. [2] Harvey P T. Common eye diseases of elderly people: identifying and treating causes of vision loss[J]. Gerontology, 2003, 49(1):1-11. [3] Mansoor S, Gupta N, Luczy-Bachman G, et al. Protective effects of memantine and epicatechin on catechol-induced toxicity on Müller cells in vitro[J]. Toxicology, 2010, 271(1):107-114. [4] Sullivan R, Penfold P, Pow D V. Neuronal migration and glial remodeling in degenerating retinas of aged rats and in nonneovascular AMD[J]. Invest Ophthalmol Vis Sci, 2003, 44(2):856-865. [5] Ambati J, Ambati B K, Yoo S H, et al. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies[J]. Surv Ophthalmol, 2003, 48(3):257-293. [6] Nowak J Z. Age-related macular degeneration (AMD): pathogenesis and therapy[J]. Pharmacol Re, 2006, 58(3):353-363. [7] Kaur C, Foulds W S, Ling E A. Blood-retinal barrier in hypoxicischaemic ditions: basic concepts, clinical features and management[J]. Prog Retin Eye Res, 2008, 27(6): 622-647. [8] Wang Z Y, Shen L J, Tu L, et al. Erythropoietin protects retinal pigment epithelial cells from oxidative damage[J]. Free Radic Biol Med, 2009, 46(8):1032-1041. [9] Ye M, Hu D, Tu L, et al. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor—induced migration of uveal melanoma cells[J]. Invest Ophthalmol Vis Sci, 2008, 49(2):497-504. [10] Beatty S, Koh H, Phil M, et al. The role of oxidative stress in the pathogenesis of age-related macular degeneration[J]. Surv Ophthalmol, 2000, 45(2):115-134. [11] Godley B F, Jin G F, Guo Y S, et al. Bcl-2 overexpression increases survival in human retinal pigment epithelial cells exposed to H2O2[J]. Exp Eye Res, 2002, 74(6):663-669. [12] Kaur C, Foulds W S, Ling E A. Blood-retinal barrier in hypoxicischaemic conditions: basic concepts, clinical features and management[J]. Prog Retin Eye Res, 2008, 27(6): 622-647. [13] Barbouti A, Doulias P T, Nousis L, et al. DNA damage and apoptosis in hydrogen peroxide-exposed Jurkat cells: bolus addition versus continuous generation of H2O2[J]. Free Radic Biol Med, 2002, 33(5): 691-702. [14] Rollet-Labelle E, Grange M J, Elbim C, et al. Hydroxyl radical as a potential intracellular mediator of polymorphonuclear neutrophil apoptosis[J]. Free Radic Biol Med, 1998, 24(4):563-572. [15] Halliwell B, Clement M V, Long L H. Hydrogen peroxide in the human body[J].FEBS Lett, 2000, 486(1):10-13. [16] Cai J, Nelson K C, Wu M, et al. Oxidative damage and protection of the RPE[J]. Prog Ret Eye Res, 2000, 19(2):205-221. [17] Fu Q L, Wu W, Wang H, et al. Up-regulated endogenous erythropoietin/erythropoietin receptor system and exogenous erythropoietin rescue retinal ganglion cells after chronic ocular hypertension[J]. Cell Mol Neurobiol, 2008, 28(2):317-329. [18] Chong Z Z, Kang J Q, Maiese K. Erythropoietin is a novel vascular protectant through activation of AKT1 and mitochondrial modulation of cysteine proteases[J]. Circulation, 2002, 106(23):2973-2979. [19] Katavetin P, Tungsanga K, Eiam-Ong S, et al. Antioxidative effects oferythropoietin[J]. Kidney Int Suppl, 2007, 107(1):10-15. [20] Digicaylioglu M, Lipton S A. Erythropoietin-mediated neuroprotection involvescross-talk between Jak2 and NF-kappaB signalling cascades[J]. Nature, 2001, 412(6847):641-647. [21] Parsa C J, Matsumoto A, Kim J, et al. Novel protective effect of erythropoietin in the infarcted heart[J]. J Clin Invest, 2003, 112(7):999-1007. [22] Kilic U, Kilic E, Soliz J, et al. Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2[J]. FASEB J, 2005, 19(3):249-251. [23] Zhong L, Bradley J, Schubert W, et al. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice[J]. Invest Ophthalmol Vis Sci, 2007, 48(3):1212-1218. [24] Tsai J C, Wu L, Worgul B, et al. Intravitreal administration of erythropoietin and preservation of retinal ganglion cells in an experimental rat model of glaucoma[J]. Curr Eye Res, 2005, 30(11):1025-1031. [25] Yamasaki M, Mishima H K, Yamashita H, et al. Neuroprotective effects of erythropoietin on glutamate and nitric oxide toxicity in primary cultured retinal ganglion cells[J]. Brain Res, 2005, 1050(1):15-26. [26] Chong Z Z, Lin S H, Kang J Q, et al. Erythropoietin prevents early and late neuronal demise through modulation of AKT1 and induction of caspase 1, 3, and 8[J]. J Neurosci Res, 2003, 71(5):659-669. [27] García-Ramírez M, Hernández C, Simó R. Expression of erythropoietin and its receptor in the human retina. A comparative study of diabetic and non-diabetic subjects[J]. Diabetes Care, 2008, 31(6):1189-1194. [28] Barbouti A, Doulias P T, Nousis L, et al. DNA damage and apoptosis in hydrogen peroxide-exposed Jurkat cells: bolus addition versus continuous generation of H2O2[J]. Free Radic Biol Med, 2002, 33(5): 691-702. [29] Zhang J, Wu Y, Jin Y, et al. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes[J]. Invest Ophthalmol Vis Sci, 2008, 49(2):732-742. [30] Bartesaghi S, Marinovich M, Corsini E, et al. Erythropoietin: a novel neuroprotective cytokine[J]. Neurotoxicology, 2005, 26(5):923-928. [31] Hanada M, Feng J, Hemmings B A. Structure, regulation and function of PKB/AKT-a major therapeutic target[J]. Biochim Biophys Acta, 2004, 1697(1):3-16. [32] Cantley L C. The phosphoinositide 3-kinase pathway[J].Science, 2002, 296(5573):1655-1657. [33] Yang P, Peairs J J, Tano R, et al. Oxidant-mediated Akt activation in human RPE cells[J]. Invest Ophthalmol Vis Sci, 2006, 47(10):4598-4606. [34] Wang Z Y, Zhao K K, Song Z M, et al. Erythropoietin as a novel therapeutic agent for atrophic age-related macular degeneration[J]. Med Hypotheses, 2009, 72(4):448-450. |
| [1] | HUANG Qiao, REN Yi, HOU Tao, LIAO Xingwei, ZHU Zi’ang, ZHAN Xiaolin, LIU Ying, YIN Shihua. Expression of EphB2 in nasopharyngeal carcinoma tissues and its correlation with clinicopathological characteristics [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 26-30. |
| [2] | MAO Yiheng, FENG Jie, HE Runtian. Study on the relationship between the effects of hyperlipidemia on retinal damage and choroid thickness [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(3): 162-167. |
| [3] | WU Cuiping, ZHU Yidan, LI Chunyan, YIN Shankai. Effect of bilirubin on the viability and proliferation of neural stem cells [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(4): 1-6. |
| [4] | ZHOU Jiamin, SONG Yuwan, SUN Yan. Research progress of pyroptosis in senile degenerative diseases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(4): 172-180. |
| [5] | XU Enpei, SUN Xianyong. Diagnosis and treatment of exudative age-related macular degeneration combined with retinal pigment epithelial detachment [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(3): 125-142. |
| [6] | WANG Luping, KOU Fangning, WANG Hao, ZHANG Canwei, WANG Yanling, YOU Ran, WU Weizhen. Effects of subretinal hyperreflective material on the visual prognosis of anti-VEGF therapy in patients with neovascular macular degeneration [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(6): 101-105. |
| [7] | YAN Fancheng, JIANG Xian, CHAI Yijie, WANG Haosen, MENG Zhaoyang, WANG Xiaolei, WANG Yanling,. miR-30-5p inhibits retinoblastoma cell proliferation by downregulating FOXG1 expression [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(5): 63-69. |
| [8] | LIU Yong, YUAN Cunli, CAO Hui, ZHENG Chengcai, CHAO Fang, XU Fenglei. CHD1L promotes proliferation, invasion and metastasis of laryngeal squamous cell carcinoma cells by EMT [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(2): 32-39. |
| [9] | XU Li, WANG Zhiyi, CHEN Wei, XUE Fei, ZHANG Yong, CHENG You, JI Junfeng, CUI Pengcheng, JIANG Manjie. Effect of MicroRNA-24 on the proliferation, migration, invasion, and apoptosis of LSCC cells [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2018, 32(6): 30-37. |
| [10] | LI Guobin, ZHANG Zhancheng, WANG Xinyan. Up-regulation of miR-200b may inhibit epithelial mesenchymal transition process to prevent the proliferation, migration, and invasion of human laryngeal cancer Hep-2 cells [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(4): 53-57. |
| [11] | ZHOU Yibo, GONG Xiaorong, YU Feng. Effects of miR-150 targeted to Nanog on proliferation and invasion of nasopharyngeal carcinoma side population cells. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(5): 79-84. |
| [12] | JI Shuaifei, ZHANG Jie, YAN Hong. Selection of intraocular lens for patients with age-related macular degeneration. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 36-39. |
| [13] | WANG Cui, YAN Xin, ZHAO Bojun. Combination of intravitreal ranibizumab with photodynamic therapy in the treatment of wet age-related macular degeneration. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 94-97. |
| [14] | . Curcumin combined with resveratrol enhances their anti-tumoral effects in the head and neck carcinoma. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(2): 67-72. |
| [15] | TIAN Xu, HUO Hong, LI Wuyi, WANG Jian, YANG Dahai. Endoscopy with Müllers maneuver and airway pressure measurement method on the evaluation of the upper airway of obstructive sleep apnea hypopnea syndrome. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(5): 29-32. |
|
||